(NASDAQ:PCRX), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX). Shareholders who purchased shares of PCRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to […]

(NASDAQ:ICLR), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required

(NASDAQ:RVNC), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NASDAQ:EPIX), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of ESSA Pharma Inc. (NASDAQ: EPIX). Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NYSE:IIPR), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR). Shareholders who purchased shares of IIPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required

(NasdaqGM:CDLX), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

(NYSE:XYZ), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Block, Inc. (NYSE: XYZ). Shareholders who purchased shares of XYZ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

(NYSE:ESTC), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Elastic N.V. (NYSE: ESTC). Shareholders who purchased shares of ESTC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

(NASDAQ:IAS), NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Integral Ad Science Holding Corp. (NASDAQ: IAS). Shareholders who purchased shares of IAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not

(NASDAQ:FLNC), SAN FRANCISCO, Feb. 26, 2025 (GLOBE NEWSWIRE) — Shares of electricity storage and software provider Fluence Energy, Inc. (NASDAQ: FLNC) closed down $6.07 (-46%) as the company continues to post declining revenue growth amid an ongoing SEC investigation into the company's alleged improper accounting practices. Hagens Berman is investigating whether Fluence Energy may have